Synaptogenix Inc. (SNPX) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Synaptogenix Inc. (SNPX)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

3.53

0.26 (7.95%)

At close: Jan 14, 2025, 2:42 PM

3.53

0.00%

After-hours Jan 14, 2025, 02:42 PM EST

undefined% (undefined)

Bid	2.82
Market Cap	4.78M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	0.88
PE Ratio (ttm)	4.01
Forward PE	n/a
Analyst	Buy

Ask	5.12
Volume	9,460
Avg. Volume (20D)	27,603
Open	3.33
Previous Close	3.27
Day's Range	3.33 - 3.58
52-Week Range	2.32 - 7.22
Beta	undefined

About SNPX

Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. It focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease. The company is also evaluating therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as fragile X syndrome, multiple sclerosis, and N...

[Show more]

Industry Biotechnology

Sector Healthcare

IPO Date Dec 8, 2020

Employees 5

Stock Exchange NASDAQ

Ticker Symbol SNPX

Website https://www.synaptogen.com

Analyst Forecast

According to 1 analyst ratings, the average rating for SNPX stock is "Buy." The 12-month stock price forecast is $14, which is an increase of 296.70% from the latest price.

Buy 100.00%

Hold 0.00%

Sell 0.00%

Stock Forecasts

Why Price Moved

3 weeks ago · Source

+19.46%

Synaptogenix shares are trading higher after the c... Unlock content with Pro Subscription

9 months ago · Source

-2.17%

Synaptogenix shares are trading lower. The company announced a 1-for-25 reverse stock split.

News

1 year ago · pennystocks.com

Best Penny Stocks To Buy Now? 10 Under $1 To Watch

Let's be honest – penny stocks priced at less than a buck hold an irresistible appeal. Even a small investment could potentially lead to insane returns.

1 year ago · pennystocks.com

Best Penny Stocks To Buy Now? 7 Under $1 To Watch

Penny stocks priced under $1 per share have attracted a dedicated following among traders seeking massive returns. While penny stocks are inherently high-risk investments, the potential reward with th...

1 year ago · pennystocks.com

Best Penny Stocks To Buy Now? 3 Under $1 To Watch

Penny stocks, typically priced below $5, have become a popular choice for day traders due to their potential for rapid gains. These stocks can offer market-beating returns in a short period, making th...

2 years ago · investorplace.com

Why Is Synaptogenix (SNPX) Stock Plummeting 70% Today?

Clinical-stage biopharmaceutical firm Synaptogenix (NASDAQ: SNPX ) demonstrated the harsh pitfalls associated with innovative medicine. Following the disclosure of disappointing results for its Phase ...

2 years ago · seekingalpha.com

Synaptogenix: Bryostatin For Alzheimer's, As Binary As Can Be

Synaptogenix has announced a readout of a Phase 2 randomized placebo-controlled trial in Alzheimer's disease for the current quarter. Preclinical work showed that its drug candidate Bryostatin-1 has s...